BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015

Mar 5, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-03-03

Reporting Person: LAPALME PIERRE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-03	Common Stock	M	10000	$11.15	Acquired	40150	Direct
2015-03-03	Common Stock	M	10000	$17.33	Acquired	50150	Direct
2015-03-03	Common Stock	S	20000	$106.57	Disposed	30150	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-03	Stock Option (right to buy Common Stock)	$11.15	M	10000	Disposed	2016-01-26	Common Stock (10000)	Direct
2015-03-03	Stock Option (right to buy Common Stock)	$17.33	M	10000	Disposed	2017-06-06	Common Stock (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1500	Indirect

Footnotes

F1: The price in column 4 is an average weighted price. The price actually received ranged from $106.20 to 106.895. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.

F2: Original option grant vests 6/48ths on July 27, 2006, and 1/48th on the 27th of each month thereafter.

F3: Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.

F4: Original option grant vests 6/48ths on December 7, 2007, and 1/48th on the 7th of each month thereafter.